E71.521

Clinical Causes: Genetic mutation: The disorder is inherited in an X-linked pattern, meaning the abnormal gene is located on the X chromosome. Inheritance from carrier mother: Sons inherit the mutated gene from their carrier mothers, who usually do not show symptoms themselves. Lack of environmental factors: The primary cause is genetic, with no known environmental or lifestyle factors directly responsible.

Key Symptoms: Progressive neurological decline: including difficulties with coordination, muscle weakness, and loss of sensation. Behavioral changes: such as irritability, cognitive decline, and difficulty with concentration. Vision and hearing problems: leading to decreased sensory perception. Adrenal insufficiency: resulting in fatigue, nausea, vomiting, and low blood pressure. Speech and swallowing difficulties: as the disease progresses. Seizures: in some cases, due to widespread nerve damage.

Diagnosis Path: Diagnosis of adolescent X-linked adrenoleukodystrophy involves a combination of clinical evaluation and laboratory tests. These include measuring very long-chain fatty acids in blood plasma, genetic testing for ABCD1 mutations, and magnetic resonance imaging (MRI) of the brain to assess neurological damage. Early detection is vital for managing symptoms and improving quality of life.

Treatment Protocols: Adrenal hormone replacement therapy: such as corticosteroids to treat adrenal insufficiency. Bone marrow or stem cell transplants: in certain cases, especially if diagnosed early, to halt or slow neurological deterioration. Supportive therapies: including physical, occupational, and speech therapies to address functional impairments. Medication management: to control seizures and other neurological symptoms. Monitoring and supportive care: regular neurological assessments and adrenal function tests.